PROTEASE INHIBITORS

Jedinjenje formule IIagdeR2 je H ili ciklopropil;R3 je granat C2-C6 alkil ili C3-C6 cikloalkil, od koji je svaki izborno supstituisan sa jednim ili dva fluoro ili sa trifluorometilom; R4 je metil ili fluoro; m je 0, 1 ili 2;R5 je H, metil ili fluoro; R6 je C1-C6 alkil;ili njegova farmaceutski prihva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ODÉN, LOURDES, SALVADORE, KAHNBERG, PIA, GRABOWSKA, URSZULA, SAMUELSSON, BERTIL, NILSSON, MAGNUS
Format: Patent
Sprache:eng ; srp
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ODÉN, LOURDES, SALVADORE
KAHNBERG, PIA
GRABOWSKA, URSZULA
SAMUELSSON, BERTIL
NILSSON, MAGNUS
description Jedinjenje formule IIagdeR2 je H ili ciklopropil;R3 je granat C2-C6 alkil ili C3-C6 cikloalkil, od koji je svaki izborno supstituisan sa jednim ili dva fluoro ili sa trifluorometilom; R4 je metil ili fluoro; m je 0, 1 ili 2;R5 je H, metil ili fluoro; R6 je C1-C6 alkil;ili njegova farmaceutski prihvatljiva so, N-oksid ili hidrat.Prijava sadrži još 16 patentnih zahteva. Compounds of the formula II:whereinR1 and R2 are independently H, F or CH3; orR1 forms an ethynyl bond and R2 is H or C3-C6 cycloalkyl which is optionally substituted with one or two substituents independently selected from methyl, CF3, OMe or halo;R3 is C1-C3 alkyl or C3-C6 cycloalkyl, either of which is optionally substituted with one or two methyl and/or a fluoro, trifluoromethyl or methoxy, when R3 is C3-C6 cycloalkyl it may alternatively be gem subsituted with fluoro;R4 is methyl or fluoro; m is 0, 1 or 2;E is a bond, or thiazolyl, optionally substituted with methyl or fluoro;A1 is CH or N,A2 is CR6R7 or NR6, provided at least one of A1 and A2 comprises N;R6 is H, C1-C4 alkyl, C1-C4 haloalkyl, C1-C3 alkyl-O-C1-C3 alkyl, or when A2 is C, R6 can also be C1-C4 alkoxy or F;R7 is H, C1-C4 alkyl or For a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RS53054B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RS53054B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RS53054B3</originalsourceid><addsrcrecordid>eNrjZBAOCPIPcXUMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDLJuriHOHrqpBfnxqcUFicmpeakl8UHBpsYGpiZOxoTkAYqIHPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROTEASE INHIBITORS</title><source>esp@cenet</source><creator>ODÉN, LOURDES, SALVADORE ; KAHNBERG, PIA ; GRABOWSKA, URSZULA ; SAMUELSSON, BERTIL ; NILSSON, MAGNUS</creator><creatorcontrib>ODÉN, LOURDES, SALVADORE ; KAHNBERG, PIA ; GRABOWSKA, URSZULA ; SAMUELSSON, BERTIL ; NILSSON, MAGNUS</creatorcontrib><description>Jedinjenje formule IIagdeR2 je H ili ciklopropil;R3 je granat C2-C6 alkil ili C3-C6 cikloalkil, od koji je svaki izborno supstituisan sa jednim ili dva fluoro ili sa trifluorometilom; R4 je metil ili fluoro; m je 0, 1 ili 2;R5 je H, metil ili fluoro; R6 je C1-C6 alkil;ili njegova farmaceutski prihvatljiva so, N-oksid ili hidrat.Prijava sadrži još 16 patentnih zahteva. Compounds of the formula II:whereinR1 and R2 are independently H, F or CH3; orR1 forms an ethynyl bond and R2 is H or C3-C6 cycloalkyl which is optionally substituted with one or two substituents independently selected from methyl, CF3, OMe or halo;R3 is C1-C3 alkyl or C3-C6 cycloalkyl, either of which is optionally substituted with one or two methyl and/or a fluoro, trifluoromethyl or methoxy, when R3 is C3-C6 cycloalkyl it may alternatively be gem subsituted with fluoro;R4 is methyl or fluoro; m is 0, 1 or 2;E is a bond, or thiazolyl, optionally substituted with methyl or fluoro;A1 is CH or N,A2 is CR6R7 or NR6, provided at least one of A1 and A2 comprises N;R6 is H, C1-C4 alkyl, C1-C4 haloalkyl, C1-C3 alkyl-O-C1-C3 alkyl, or when A2 is C, R6 can also be C1-C4 alkoxy or F;R7 is H, C1-C4 alkyl or For a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.</description><language>eng ; srp</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140430&amp;DB=EPODOC&amp;CC=RS&amp;NR=53054B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140430&amp;DB=EPODOC&amp;CC=RS&amp;NR=53054B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ODÉN, LOURDES, SALVADORE</creatorcontrib><creatorcontrib>KAHNBERG, PIA</creatorcontrib><creatorcontrib>GRABOWSKA, URSZULA</creatorcontrib><creatorcontrib>SAMUELSSON, BERTIL</creatorcontrib><creatorcontrib>NILSSON, MAGNUS</creatorcontrib><title>PROTEASE INHIBITORS</title><description>Jedinjenje formule IIagdeR2 je H ili ciklopropil;R3 je granat C2-C6 alkil ili C3-C6 cikloalkil, od koji je svaki izborno supstituisan sa jednim ili dva fluoro ili sa trifluorometilom; R4 je metil ili fluoro; m je 0, 1 ili 2;R5 je H, metil ili fluoro; R6 je C1-C6 alkil;ili njegova farmaceutski prihvatljiva so, N-oksid ili hidrat.Prijava sadrži još 16 patentnih zahteva. Compounds of the formula II:whereinR1 and R2 are independently H, F or CH3; orR1 forms an ethynyl bond and R2 is H or C3-C6 cycloalkyl which is optionally substituted with one or two substituents independently selected from methyl, CF3, OMe or halo;R3 is C1-C3 alkyl or C3-C6 cycloalkyl, either of which is optionally substituted with one or two methyl and/or a fluoro, trifluoromethyl or methoxy, when R3 is C3-C6 cycloalkyl it may alternatively be gem subsituted with fluoro;R4 is methyl or fluoro; m is 0, 1 or 2;E is a bond, or thiazolyl, optionally substituted with methyl or fluoro;A1 is CH or N,A2 is CR6R7 or NR6, provided at least one of A1 and A2 comprises N;R6 is H, C1-C4 alkyl, C1-C4 haloalkyl, C1-C3 alkyl-O-C1-C3 alkyl, or when A2 is C, R6 can also be C1-C4 alkoxy or F;R7 is H, C1-C4 alkyl or For a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAOCPIPcXUMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDLJuriHOHrqpBfnxqcUFicmpeakl8UHBpsYGpiZOxoTkAYqIHPw</recordid><startdate>20140430</startdate><enddate>20140430</enddate><creator>ODÉN, LOURDES, SALVADORE</creator><creator>KAHNBERG, PIA</creator><creator>GRABOWSKA, URSZULA</creator><creator>SAMUELSSON, BERTIL</creator><creator>NILSSON, MAGNUS</creator><scope>EVB</scope></search><sort><creationdate>20140430</creationdate><title>PROTEASE INHIBITORS</title><author>ODÉN, LOURDES, SALVADORE ; KAHNBERG, PIA ; GRABOWSKA, URSZULA ; SAMUELSSON, BERTIL ; NILSSON, MAGNUS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RS53054B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; srp</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ODÉN, LOURDES, SALVADORE</creatorcontrib><creatorcontrib>KAHNBERG, PIA</creatorcontrib><creatorcontrib>GRABOWSKA, URSZULA</creatorcontrib><creatorcontrib>SAMUELSSON, BERTIL</creatorcontrib><creatorcontrib>NILSSON, MAGNUS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ODÉN, LOURDES, SALVADORE</au><au>KAHNBERG, PIA</au><au>GRABOWSKA, URSZULA</au><au>SAMUELSSON, BERTIL</au><au>NILSSON, MAGNUS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROTEASE INHIBITORS</title><date>2014-04-30</date><risdate>2014</risdate><abstract>Jedinjenje formule IIagdeR2 je H ili ciklopropil;R3 je granat C2-C6 alkil ili C3-C6 cikloalkil, od koji je svaki izborno supstituisan sa jednim ili dva fluoro ili sa trifluorometilom; R4 je metil ili fluoro; m je 0, 1 ili 2;R5 je H, metil ili fluoro; R6 je C1-C6 alkil;ili njegova farmaceutski prihvatljiva so, N-oksid ili hidrat.Prijava sadrži još 16 patentnih zahteva. Compounds of the formula II:whereinR1 and R2 are independently H, F or CH3; orR1 forms an ethynyl bond and R2 is H or C3-C6 cycloalkyl which is optionally substituted with one or two substituents independently selected from methyl, CF3, OMe or halo;R3 is C1-C3 alkyl or C3-C6 cycloalkyl, either of which is optionally substituted with one or two methyl and/or a fluoro, trifluoromethyl or methoxy, when R3 is C3-C6 cycloalkyl it may alternatively be gem subsituted with fluoro;R4 is methyl or fluoro; m is 0, 1 or 2;E is a bond, or thiazolyl, optionally substituted with methyl or fluoro;A1 is CH or N,A2 is CR6R7 or NR6, provided at least one of A1 and A2 comprises N;R6 is H, C1-C4 alkyl, C1-C4 haloalkyl, C1-C3 alkyl-O-C1-C3 alkyl, or when A2 is C, R6 can also be C1-C4 alkoxy or F;R7 is H, C1-C4 alkyl or For a pharmaceutically acceptable salt, N-oxide or hydrate thereof, have utility in the treatment of disorders characterized by inappropriate expression or activation of cathepsin K, such as osteoporosis, osteoarthritis, rheumatoid arthritis or bone metastases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; srp
recordid cdi_epo_espacenet_RS53054B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PROTEASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A53%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OD%C3%89N,%20LOURDES,%20SALVADORE&rft.date=2014-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERS53054B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true